Light Bright Neurons

Neurons engineered to light up when they fire could help researchers study more precisely how the brain works.

By | December 2, 2011


Borrowing a gene from a Dead Sea microorganism, researchers at Harvard University have developed neurons that fluoresce in response to electrical activity, providing the first ever visual cue for neuronal firing.

“It’s very exciting. In terms of basic biology, there are a number of things we can now do which we’ve never been able to do,” lead researcher Adam Cohen told the Harvard Gazette. “We may someday even be able to study how these signals move in living animals.”

To achieve this feat, Cohen and his colleagues transfected cultured rat hippocampal neurons with a viral vector carrying the gene for a microbial rhodopsin protein called Archaerhodopsin 3 (Arch) from an arcahea species found in the Dead Sea bordering Jordan and Israel. The resulting neurons lit up in response to the voltage changes that occurred when neurons fired, allowing the researchers to visualize individual action potentials, according to the study published in this week (November 27) in Nature Methods. Thus, unlike optogenetics, which uses light to activate neurons, Cohen and his colleagues are taking advantage of a photostimulated protein to see what brain cells are doing.

“Before, the best way to make a measurement of the electrical activity in a cell was to stick a little electrode into it and record the results on a volt meter,” Cohen told the Gazette. “The issue, however, was that you were only measuring the voltage at one point, you weren’t seeing a spatial map of how signals propagate. Now, we will be able to study how the signal spreads, whether it moves through all neurons at the same speed, and even how signals change if the cells are undergoing something akin to learning.”

(Hat tip to Wired Science)

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham